The potential of three-dimensional printing for pediatric oral solid dosage forms
By: Klemen Kreft, Marina Fanous and Volker Möckel
References
- J. Breitkreutz and J. Boos, Paediatric and geriatric drug delivery, Expert Opin. Drug Deliv. 4 (2007) 37–45; https://doi.org/10.1517/17425247.4.1.37
- G. L. Kearns, S. M. Abdel-Rahman, S. W. Alander, D. L. Blowey, J. S. Leeder and R. E. Kauffman, Developmental pharmacology – Drug disposition, action, and therapy in infants and children, N. Engl. J. Med. 349(12) (2003) 1157–1167; https://doi.org/10.1056/NEJMra035092
- A. Iyire and A. R. Mohammed, Multiparticulate Systems for Paediatric Drug Delivery, in Multiparticulate Drug Delivery (Ed. A. Rajabi-Siahboomi), Springer, New York 2017, pp. 213–236.
- S. M. Hanning, F. L. Lopez, I. C. K. Wong, T. B. Ernest, C. Tuleu and M. Orlu Gul, Patient centric formulations for paediatrics and geriatrics: Similarities and differences, Int. J. Pharm. 512(2) (2016) 355–359; https://doi.org/10.1016/j.ijpharm.2016.03.017
- K. Grießmann, J. Breitkreutz, M. Schubert-Zsilavecz and M. Abdel-Tawab, Dosing accuracy of measuring devices provided with antibiotic oral suspensions, Paediatr. Perinat. Drug Ther. 8(2) (2007) 61–70; https://doi.org/10.1185/146300907X178950
- World Health Organization, Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries: Flexible Solid Oral Dosage: Dispersible formulations of amoxicillin, World Health Organization, Geneva 2014, pp. 17.
- F. Liu, S. Ranmal, H. K. Batchelor, M. Orlu-Gul, T. B. Ernest, I. W. Thomas, T. Flanagan and C. Tuleu, Patient-centered pharmaceutical design to improve acceptability of medicines: Similarities and differences in paediatric and geriatric populations, Drugs 74(16) (2014) 1871–1889; https://doi.org/10.1007/s40265-014-0297-2
- Y. J. Manrique-Torres, D. J. Lee, F. Islam, L. M. Nissen, J. A. Y. Cichero, J. R. Stokes and K. J. Steadman, Crushed tablets: Does the administration of food vehicles and thickened fluids to aid medication swallowing alter drug release?, J. Pharm. Pharm. Sci. 17(2) (2014) 207–219; https://doi.org/10.18433/j39w3v
- I. Bácskay, Z. Ujhelyi, P. Fehér and P. Arany, The evolution of the 3D-printed drug delivery systems: A review, Pharmaceutics 14(7) (2022) Article ID 1312 (30 pages); https://doi.org/10.3390/pharmaceutics14071312
- C. L. Ventola, Medical applications for 3D printing: Current and projected uses, P T. 39(10) (2014) 704–711.
- S. Singh, M. Kumar, A. A. Doolaanea and U. K. Mandal, A recent review on 3D-printing: Scope and challenges with special focus on pharmaceutical field, Curr. Pharm. Des. 28(30) (2022) 2488–2507; https://doi.org/10.2174/1381612828666220623091629
- G. Auriemma, C. Tommasino, G. Falcone, T. Esposito, C. Sardo and R. P. Aquino, Additive manufacturing strategies for personalized drug delivery systems and medical devices: Fused filament fabrication and semi solid extrusion, Molecules 27(9) (2022) Article ID 2784 (63 pages); https://doi.org/10.3390/molecules27092784
- M. A. Alhnan, T. C. Okwuosa, M. Sadia, K. W. Wan, W. Ahmed and B. Arafat, Emergence of 3D printed dosage forms: Opportunities and challenges, Pharm. Res. 33(8) (2016) 1817–1832; https://doi.org/10.1007/s11095-016-1933-1
- Z. Rahman, S. F. Barakh Ali, T. Ozkan, N. A. Charoo, I. K. Reddy and M. A. Khan, Additive manufacturing with 3D printing: Progress from bench to bedside, AAPS J. 20(6) (2018) Article ID 101 (14 pages); https://doi.org/10.1208/s12248-018-0225-6
- R. Daly, T. S. Harrington, G. D. Martin and I. M. Hutchings, Inkjet printing for pharmaceutics – A review of research and manufacturing, Int. J. Pharm. 494(2) (2015) 554–567; https://doi.org/10.1016/j.ijpharm.2015.03.017
- J. H. Kim, K. Kim and H. E. Jin, Three-dimensional printing for oral pharmaceutical dosage forms, J. Pharm. Investig. 52 (2022) 293–317; https://doi.org/10.1007/s40005-022-00561-3
- A. Awad, S. J. Trenfield, S. Gaisford and A. W. Basit, 3D printed medicines: A new branch of digital healthcare, Int. J. Pharm. 548(1) (2018) 586–596; https://doi.org/10.1016/j.ijpharm.2018.07.024
- M. R. P. Araújo, L. L. Sa-Barreto, T. Gratieri, G. M. Gelfuso and M. Cunha-Filho, The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality, Pharmaceutics 11(3) (2019) Article ID 128 (14 pages); https://doi.org/10.3390/pharmaceutics11030128
- G. M. Khalid and N. Billa, Solid dispersion formulations by FDM 3D Printing – A review, Pharmaceutics 14(4) (2022) Article ID 690 (23 pages); https://doi.org/10.3390/pharmaceutics14040690
- L. Krueger, J. A. Miles and A. Popat, 3D printing hybrid materials using fused deposition modelling for solid oral dosage forms, J. Control. Release 351 (2022) 444–455; https://doi.org/10.1016/j.jconrel.2022.09.032
- A. Konta, M. García-Piña and D. Serrano, Personalised 3D printed medicines: Which techniques and polymers are more successful?, Bioengineering 4(4) (2017) Article ID 79 (16 pages); https://doi.org/10.3390/bioengineering4040079
- S. Cailleaux, N. M. Sanchez-Ballester, Y. A. Gueche, B. Bataille and I. Soulairol, Fused deposition modeling (FDM), the new asset for the production of tailored medicines, J. Control. Release 330 (2021) 821–841; https://doi.org/10.1016/j.jconrel.2020.10.056
- L. Hoffmann, J. Breitkreutz and J. Quodbach, Fused deposition modeling (FDM) 3D printing of the thermo-sensitive peptidomimetic drug enalapril maleate, Pharmaceutics 14(11) (2022) Article ID 2411 (14 pages); https://doi.org/10.3390/pharmaceutics14112411
- A. Goyanes, N. Allahham, S. J. Trenfield, E. Stoyanov, S. Gaisford and A. W. Basit, Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process, Int. J. Pharm. 567 (2019) Article ID 118471 (7 pages); https://doi.org/10.1016/j.ijpharm.2019.118471
- J. Boniatti, P. Januskaite, L. B. da Fonseca, A. L. Viçosa, F. C. Amendoeira, C. Tuleu, A. W. Basit, A. Goyanes and M.-I. Ré, Direct powder extrusion 3D printing of praziquantel to overcome neglected disease formulation challenges in paediatric populations, Pharmaceutics 13(8) (2021) Article ID 1114 (19 pages); https://doi.org/10.3390/pharmaceutics13081114
- S. A. Khaled, J. C. Burley, M. R. Alexander and C. J. Roberts, Desktop 3D printing of controlled release pharmaceutical bilayer tablets, Int. J. Pharm. 461(1–2) (2014) 105–111; https://doi.org/10.1016/j.ijpharm.2013.11.021
- I. Seoane-Viaño, P. Januskaite, C. Alvarez-Lorenzo, A. W. Basit and A. Goyanes, Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges, J. Control. Release 332 (2021) 367–389; https://doi.org/10.1016/j.jconrel.2021.02.027
- D. R. Serrano, A. Kara, I. Yuste, F. C. Luciano, B. Ongoren, B. J. Anaya, G. Molina, L. Diez, B. I. Ramirez, I. O. Ramirez, S. A. Sánchez-Guirales, R. Fernández-García, L. Bautista, H. K. Ruiz and A. Lalatsa, 3D Printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals, Pharmaceutics 15(2) (2023) Article ID 313 (28 pages); https://doi.org/10.3390/pharmaceutics15020313
- M. S. Algahtani, A. A. Mohammed and J. Ahmad, Extrusion-based 3D printing for pharmaceuticals: Contemporary research and applications, Curr. Pharm. Des. 24(42) (2018) 4991–5008; https://doi.org/10.2174/1381612825666190110155931
- N. A. Charoo, S. F. Barakh Ali, E. M. Mohamed, M. A. Kuttolamadom, T. Ozkan, M. A. Khan and Z. Rahman, Selective laser sintering 3D printing – an overview of the technology and pharmaceutical applications, Drug Dev. Ind. Pharm. 46(6) (2020) 869–877; https://doi.org/10.1080/03639045.2020.1764027
- F. Fina, A. Goyanes, S. Gaisford and A. W. Basit, Selective laser sintering (SLS) 3D printing of medicines, Int. J. Pharm. 529(1–2) (2017) 285–293; https://doi.org/10.1016/j.ijpharm.2017.06.082
- D. Muhindo, R. Elkanayati, P. Srinivasan, M. A. Repka and E. A. Ashour, Recent advances in the applications of additive manufacturing (3D printing) in drug delivery: A comprehensive review, AAPS PharmSciTech. 24(2) (2023) Article ID 57 (22 pages); https://doi.org/10.1208/s12249-023-02524-9
- O. L. Okafor-Muo, H. Hassanin, R. Kayyali and A. ElShaer, 3D printing of solid oral dosage forms: Numerous challenges with unique opportunities, J. Pharm. Sci. 109(12) (2020) 3535–3550; https://doi.org/10.1016/j.xphs.2020.08.029
- Y. Wang, A. Müllertz and J. Rantanen, Additive manufacturing of solid products for oral drug delivery using binder jetting three-dimensional printing, AAPS PharmSciTech. 23(6) (2022) Article ID 196 (21 pages); https://doi.org/10.1208/s12249-022-02321-w
- J. Goole and K. Amighi, 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems, Int. J. Pharm. 499(1–2) (2016) 376–394; https://doi.org/10.1016/j.ijpharm.2015.12.071
- L. K. Prasad and H. Smyth, 3D Printing technologies for drug delivery: A review, Drug Dev. Ind. Pharm. 42(7) (2016) 1019–1031; https://doi.org/10.3109/03639045.2015.1120743
- M. Kozakiewicz-Latała, K. P. Nartowski, A. Dominik, K. Malec, A. M. Gołkowska, A. Złocińska, M. Rusińska, P. Szymczyk-Ziółkowska, G. Ziółkowski, A. Górniak and B. Karolewicz, Binder jetting 3D printing of challenging medicines: From low dose tablets to hydrophobic molecules, Eur. J. Pharm. Biopharm. 170 (2022) 144–159; https://doi.org/10.1016/j.ejpb.2021.11.001
- S. Y. Chang, J. Jin, J. Yan, X. Dong, B. Chaudhuri, K. Nagapudi and A. W. K. Ma, Development of a pilot-scale HuskyJet binder jet 3D printer for additive manufacturing of pharmaceutical tablets, Int. J. Pharm. 605 (2021) Article ID 120791 (11 pages); https://doi.org/10.1016/j.ijpharm.2021.120791
- F. Fina, C. M. Madla, A. Goyanes, J. Zhang, S. Gaisford and A. W. Basit, Fabricating 3D printed orally disintegrating printlets using selective laser sintering, Int. J. Pharm. 541(1–2) (2018) 101–107; https://doi.org/10.1016/j.ijpharm.2018.02.015
- N. Allahham, F. Fina, C. Marcuta, L. Kraschew, W. Mohr, S. Gaisford, A. W. Basit and A. Goyanes, Selective laser sintering 3D printing of orally disintegrating printlets containing ondansetron, Pharmaceutics 12(2) (2020) Article ID 10 (13 pages); https://doi.org/10.3390/pharmaceutics12020110
- X. Chen, S. Wang, J. Wu, S. Duan, X. Wang, X. Hong, X. Han, C. Li, D. Kang, Z. Wang and A. Zheng, The application and challenge of binder jet 3D printing technology in pharmaceutical manufacturing, Pharmaceutics 14(12) (2022) Article ID 2589 (20 pages); https://doi.org/10.3390/pharmaceutics14122589
- Z. Wang, X. Han, R. Chen, J. Li, J. Gao, H. Zhang, N. Liu, X. Gao and A. Zheng, Innovative color jet 3D printing of levetiracetam personalized paediatric preparations, Asian J. Pharm. Sci. 16(3) (2021) 374–386; https://doi.org/10.1016/j.ajps.2021.02.003
- K. Kreft, Z. Lavrič, T. Stanić, P. Perhavec and R. Dreu, Influence of the binder jetting process parameters and binder liquid composition on the relevant attributes of 3D-printed tablets, Pharmaceutics 14(8) (2022) Article ID 1568 (21 pages); https://doi.org/10.3390/pharmaceutics14081568
- K. Sen, T. Mehta, S. Sansare, L. Sharifi, A. W. K. Ma and B. Chaudhuri, Pharmaceutical applications of powder-based binder jet 3D printing process – A review, Adv. Drug Deliv. Rev. 177 (2021) Article ID 113943 (12 pages); https://doi.org/10.1016/j.addr.2021.113943
- S. Pravin and A. Sudhir, Integration of 3D printing with dosage forms: A new perspective for modern healthcare, Biomed. Pharmacother. 107 (2018) 146–154; https://doi.org/10.1016/j.biopha.2018.07.167
- P. Lakkala, S. R. Munnangi, S. Bandari and M. Repka, Additive manufacturing technologies with emphasis on stereolithography 3D printing in pharmaceutical and medical applications: A review, Int. J. Pharm. X 5 (2023) Article ID 100159 (16 pages); https://doi.org/10.1016/j.ijpx.2023.100159
- X. Xu, P. Robles-Martinez, C. M. Madla, F. Joubert, A. Goyanes, A. W. Basit and S. Gaisford, Stereo-lithography (SLA) 3D printing of an antihypertensive polyprintlet: Case study of an unexpected photopolymer-drug reaction, Addit. Manuf. 33 (2020) Article ID 101071 (8 pages); https://doi.org/10.1016/j.addma.2020.101071
- E. V. Blynskaya, S. V. Tishkov, K. V. Alekseev, A. A. Vetcher, A. I. Marakhova and D. T. Rejepov, Polymers in Technologies of additive and inkjet printing of dosage formulations, Polymers 14(13) (2022) Article ID 2543 (13 pages); https://doi.org/10.3390/polym14132543
- M. Scarpa, S. Stegemann, W.-K. Hsiao, H. Pichler, S. Gaisford, M. Bresciani, A. Paudel and M. Orlu, Orodispersible films: Towards drug delivery in special populations, Int. J. Pharm. 523(1) (2017) 327–335; https://doi.org/10.1016/j.ijpharm.2017.03.018
- M. S. Gupta, T. P. Kumar, R. Davidson, G. R. Kuppu, K. Pathak and D. V. Gowda, Printing methods in the production of orodispersible films, AAPS PharmSci.Tech. 22(3) (2021) Article ID 129 (17 pages); https://doi.org/10.1208/s12249-021-01990-3
- B. Morath, S. Sauer, M. Zaradzki and A. H. Wagner, Orodispersible films – Recent developments and new applications in drug delivery and therapy, Biochem. Pharmacol. 200 (2022) Article ID 115036 (13 pages); https://doi.org/10.1016/j.bcp.2022.115036
- P. Carou-Senra, J. J. Ong, B. M. Castro, I. Seoane-Viaño, L. Rodríguez-Pombo, P. Cabalar, C. Alvarez-Lorenzo, A. W. Basit, G. Pérez and A. Goyanes, Predicting pharmaceutical inkjet printing outcomes using machine learning, Int. J. Pharm. X. 5 (2023) Article ID 100181 (12 pages); https://doi.org/10.1016/j.ijpx.2023.100181
- R. D. Boehm, P. R. Miller, J. Daniels, S. Stafslien and R. J. Narayan, Inkjet printing for pharmaceutical applications, Materials Today 17(5) (2014) 247–252; https://doi.org/10.1016/j.mattod.2014.04.027
- H. Öblom, E. Sjöholm, M. Rautamo and N. Sandler, Towards printed pediatric medicines in hospital pharmacies: Comparison of 2D and 3D-printed orodispersible warfarin films with conventional oral powders in unit dose sachets, Pharmaceutics 11(7) (2019) Article ID 334 (33 pages); https://doi.org/10.3390/pharmaceutics11070334
- M. Preis and H. Öblom, 3D-printed drugs for children – Are we ready yet?, AAPS PharmSci.Tech. 18(2) (2017) 303–308; https://doi.org/10.1208/s12249-016-0704-y
- T. Tagami, E. Ito, R. Kida, K. Hirose, T. Noda and T. Ozeki, 3D printing of gummy drug formulations composed of gelatin and an HPMC-based hydrogel for pediatric use, Int. J. Pharm. 594 (2021) Article ID 120118 (7 pages); https://doi.org/10.1016/j.ijpharm.2020.120118
- N. Scoutaris, S. A. Ross and D. Douroumis, 3D printed “Starmix” drug loaded dosage forms for paediatric applications, Pharm. Res. 35(2) (2018) Article ID 34 (11 pages); https://doi.org/10.1007/s11095-017-2284-2
- H. K. Batchelor and J. F. Marriott, Formulations for children: problems and solutions, Br. J. Clin. Pharmacol. 79(3) (2015) 405–418; https://doi.org/10.1111/bcp.12268
- K. R. Mazarura, P. Kumar and Y. E. Choonara, Customized 3D printed multi-drug systems: an effective and efficient approach to polypharmacy, Expert Opin. Drug Deliv. 19(9) (2022) 1149–1163; https://doi.org/10.1080/17425247.2022.2121816
- Afsana, V. Jain, N. Haider and K. Jain, 3D printing in personalized drug delivery, Curr. Pharm. Des. 24(42) (2019) 5062–5071; https://doi.org/10.2174/1381612825666190215122208
- M. Bogdahn, J. Torner, J. Krause, M. Grimm and W. Weitschies, Influence of the geometry of 3D printed solid oral dosage forms on their swallowability, Eur. J. Pharm. Biopharm. 167 (2021) 65–72; https://doi.org/10.1016/j.ejpb.2021.07.009
- L. Bracken, E. McDonough, S. Ashleigh, F. Wilson, J. Shakeshaft, U. Ohia, P. Mistry, H. Jones, N. Kanji, F. Liu and M. Peak, Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)), BMJ Open. 10(10) (2020) e036508 (11 pages); https://doi.org/10.1136/bmjopen-2019-036508
- J. Krause, L. Müller, D. Sarwinska, A. Seidlitz, M. Sznitowska and W. Weitschies, 3D printing of mini tablets for pediatric use, Pharmaceuticals 14(2) (2021) Article ID 143 (16 pages); https://doi.org/10.3390/ph14020143
- S. Palekar, P. K. Nukala, S. M. Mishra, T. Kipping and K. Patel, Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen, Int. J. Pharm. 556 (2019) 106–116; https://doi.org/10.1016/j.ijpharm.2018.11.062
- P. Januskaite, X. Xu, S. R. Ranmal, S. Gaisford, A. W. Basit, C. Tuleu and A. Goyanes, I spy with my little eye: A paediatric visual preferences survey of 3D printed tablets, Pharmaceutics 12(11) (2020) Article ID 1100 (16 pages); https://doi.org/10.3390/pharmaceutics12111100
- A. Goyanes, C. M. Madla, A. Umerji, G. Duran Piñeiro, J. M. Giraldez Montero, M. J. Lamas Diaz, M. Gonzalez Barcia, F. Taherali, P. Sánchez-Pintos, M.-L. Couce, S. Gaisford and A. W. Basit, Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients, Int. J. Pharm. 567 (2019) Article ID 118497 (8 pages); https://doi.org/10.1016/j.ijpharm.2019.118497
- W. Jamróz, J. Szafraniec, M. Kurek and R. Jachowicz, 3D printing in pharmaceutical and medical applications – Recent achievements and challenges, Pharm. Res. 35 (2018) Article ID 176 (22 pages); https://doi.org/10.1007/s11095-018-2454-x
- J. Yoo, T. J. Bradbury, T. J. Bebb, J. Iskra, L. Surprenant and T. G. West, Three-dimensional Printing System and Equipment Assembly, U.S. Pat. 8,888,480, 18 Nov 2014.
- A. G. Tabriz, M. S. Mithu, M. D. Antonijevic, L. Vilain, Y. Derrar, C. Grau, A. Morales, O. L. Katsamenis and D. Douroumis, 3D printing of LEGO® like designs with tailored release profiles for treatment of sleep disorder, Int. J. Pharm. 632 (2023) Article ID 122574 (13 pages); https://doi.org/10.1016/j.ijpharm.2022.122574
- Z. Zhang, S. Feng, A. Almotairy, S. Bandari and M. A. Repka, Development of multifunctional drug delivery system via hot-melt extrusion paired with fused deposition modeling 3D printing techniques, Eur. J. Pharm. Biopharm. 183 (2023) 102–111; https://doi.org/10.1016/j.ejpb.2023.01.004
- J. dos Santos, G. S. da Silva, M. C. Velho and R. C. R. Beck, Eudragit®: A versatile family of polymers for hot melt extrusion and 3D printing processes in pharmaceutics, Pharmaceutics 13(9) (2021) Article ID 1424 (36 pages); https://doi.org/10.3390/pharmaceutics13091424
- R. Li, Y. Pan, D. Chen, X. Xu, G. Yan and T. Fan, Design, Preparation and in vitro evaluation of core-shell fused deposition modelling 3D-printed verapamil hydrochloride pulsatile tablets, Pharmaceutics 14(2) (2022) Article ID 437 (15 pages); https://doi.org/10.3390/pharmaceutics14020437
- A. Maroni, A. Melocchi, F. Parietti, A. Foppoli, L. Zema and A. Gazzaniga, 3D printed multi-compartment capsular devices for two-pulse oral drug delivery, J. Control. Release 268 (2017) 10–18; https://doi.org/10.1016/j.jconrel.2017.10.008
- H. Windolf, R. Chamberlain, J. Breitkreutz and J. Quodbach, 3D printed mini-floating-polypill for Parkinson’s disease: Combination of levodopa, benserazide, and pramipexole in various dosing for personalized therapy, Pharmaceutics 14(5) (2022) Article ID 931 (22 pages); https://doi.org/10.3390/pharmaceutics14050931
- A. Alayoubi, A. Zidan, S. Asfari, M. Ashraf, L. Sau and M. Kopcha, Mechanistic understanding of the performance of personalized 3D-printed cardiovascular polypills: A case study of patient-centered therapy, Int. J. Pharm. 617 (2022) Article ID 121599 (13 pages); https://doi.org/10.1016/j.ijpharm.2022.121599
- T. D. Reynolds, S. A. Mitchell and K. M. Balwinski, Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets, Drug Dev. Ind. Pharm. 28(4) (2002) 457–466; https://doi.org/10.1081/ddc-120003007
- H. Windolf, R. Chamberlain and J. Quodbach, Predicting drug release from 3D printed oral medicines based on the surface area to volume ratio of tablet geometry, Pharmaceutics 13(9) (2021) Article ID 1453 (22 pages); https://doi.org/10.3390/pharmaceutics13091453
- A. Goyanes, P. Robles Martinez, A. Buanz, A. W. Basit and S. Gaisford, Effect of geometry on drug release from 3D printed tablets, Int. J. Pharm. 494(2) (2015) 657–663; https://doi.org/10.1016/j.ijpharm.2015.04.069
- M. Cui, H. Pan, D. Fang, S. Qiao, S. Wang and W. Pan, Fabrication of high drug loading levetiracetam tablets using semi-solid extrusion 3D printing, J. Drug Deliv. Sci. Technol. 57 (2020) Article ID 101683 (9 pages); https://doi.org/10.1016/j.jddst.2020.101683
- S. A. Khaled, M. R. Alexander, D. J. Irvine, R. D. Wildman, M. J. Wallace, S. Sharpe, J. Yoo and C. J. Roberts, Extrusion 3D printing of paracetamol tablets from a single formulation with tunable release profiles through control of tablet geometry, AAPS PharmSciTech. 19(8) (2018) 3403–3413; https://doi.org/10.1208/s12249-018-1107-z
- M. Moreira and M. Sarraguça, How can oral paediatric formulations be improved? A challenge for the XXI century, Int. J. Pharm. 590 (2020) Article ID 119905 (9 pages); https://doi.org/10.1016/j.ijpharm.2020.119905
- A. G. Tabriz, D. H. G. Fullbrook, L. Vilain, Y. Derrar, U. Nandi, C. Grau, A. Morales, G. Hooper, Z. Hiezl and D. Douroumis, Personalised tasted masked chewable 3D printed fruit-chews for paediatric patients, Pharmaceutics 13(8) (2021) Article ID 1301 (14 pages); https://doi.org/10.3390/pharmaceutics13081301
- T. Tracy, L. Wu, X. Liu, S. Cheng and X. Li, 3D printing: Innovative solutions for patients and pharmaceutical industry, Int. J. Pharm. 631 (2023) 122480; https://doi.org/10.1016/j.ijpharm.2022.122480
- I. Seoane-Viaño, S. J. Trenfield, A. W. Basit and A. Goyanes, Translating 3D printed pharmaceuticals: From hype to real-world clinical applications, Adv. Drug Deliv. Rev. 174 (2021) 553–575; https://doi.org/10.1016/j.addr.2021.05.003
- A. Awad, S. J. Trenfield, A. Goyanes, S. Gaisford and A. W. Basit, Reshaping drug development using 3D printing, Drug Discov. Today 23(8) (2018) 1547–1555; https://doi.org/10.1016/j.drudis.2018.05.025
- S. J. Trenfield, A. Awad, A. Goyanes, S. Gaisford and A. W. Basit, 3D Printing pharmaceuticals: Drug development to frontline care, Trends Pharmacol. Sci. 39(5) (2018) 440–451; https://doi.org/10.1016/j.tips.2018.02.006
- J. Rahman and J. Quodbach, Versatility on demand – The case for semi-solid micro-extrusion in pharmaceutics, Adv. Drug Deliv. Rev. 172 (2021) 104–126; https://doi.org/10.1016/j.addr.2021.02.013
- V. L. Tiase, W. Hull, M. M. McFarland, K. A. Sward, G. Del Fiol, C. Staes, C. Weir and M. R. Cummins, Patient-generated health data and electronic health record integration: Protocol for a scoping review, BMJ Open 9(12) (2019) e033073 (5 pages); https://doi.org/10.1136/bmjopen-2019-033073
- C. Petersen, Use of patient-generated health data for shared decision-making in the clinical environment: Ready for prime time, mHealth 7 (2021) Article ID 39 (3 pages); https://doi.org/10.21037/mhealth.2020.03.05
- G. T. Tucker, Personalized drug dosage – closing the loop, Pharm. Res. 34(8) (2017) 1539–1543; https://doi.org/10.1007/s11095-016-2076-0
- A. A. Kawu, L. Hederman, J. Doyle and D. O’Sullivan, Patient generated health data and electronic health record integration, governance and socio-technical issues: A narrative review, Inform. Med. Unlocked 37 (2023) Article ID 101153 (12 pages); https://doi.org/10.1016/j.imu.2022.101153
- V. L. Tiase, K. A. Sward, G. Del Fiol, C. Staes, C. Weir and M. R. Cummins, Patient-generated health data in pediatric asthma: Exploratory study of providers’ information needs, JMIR Pediatr. Parent. 4(1) (2021) e25413 (8 pages); https://doi.org/10.2196/25413
- D. Cadillo Chandler and M. Salmi, Law and Technology of 3D Printing and Medical Devices, in 3D Printing, Intellectual Property and Innovation: Insights from Law and Technology (Ed. R. M. Ballardini, M. Norrgård, J. Partanen), Kluwer Law International, Alphen aan den Rijn 2017, pp. 149–168.
- D. Karalia, A. Siamidi, V. Karalis and M. Vlachou, 3D-printed oral dosage forms: Mechanical properties, computational approaches and applications, Pharmaceutics 13(9) (2021) Article ID 1401 (37 pages); https://doi.org/10.3390/pharmaceutics13091401
- H. Amekyeh, F. Tarlochan and N. Billa, Practicality of 3D printed personalized medicines in therapeutics, Front. Pharmacol. 12 (2021) Article ID 646836 (15 pages); https://doi.org/10.3389/fphar.2021.646836
- L. A. Melnyk and M. O. Oyewumi, Integration of 3D printing technology in pharmaceutical compounding: Progress, prospects, and challenges, Ann. 3D Print. Med. 4 (2021) Article ID 100035 (9 pages)100035; https://doi.org/10.1016/j.stlm.2021.100035
- M. Alomari, F. H. Mohamed, A. W. Basit and S. Gaisford, Personalised dosing: Printing a dose of one’s own medicine, Int. J. Pharm. 494(2) (2015) 568–577; https://doi.org/10.1016/j.ijpharm.2014.12.006
- O. Goh, W. Goh, S. Lim, G. Hoo, R. Liew and T. Ng, Preferences of healthcare professionals on 3D-printed tablets: A pilot study, Pharmaceutics 14(7) (2022) Article ID 1521 (15 pages); https://doi.org/10.3390/pharmaceutics14071521
- Y. E. Choonara, L. C. du Toit, P. Kumar, P. P. D. Kondiah and V. Pillay, 3D-printing and the effect on medical costs: a new era?, Expert Rev. Pharmacoecon. Outcomes Res. 16(1) (2016) 23–32; https://doi.org/10.1586/14737167.2016.1138860
- W. K. Hsiao, B. Lorber, H. Reitsamer and J. Khinast, 3D printing of oral drugs: A new reality or hype?, Expert Opin. Drug Deliv. 15(1) (2018) 1–4; https://doi.org/10.1080/17425247.2017.1371698
- United States Food and Drug Administration, Technical Considerations for Additive Manufactured Medical Devices: Guidance for Industry and Food and Drug Administration Staff, December 2017; https://www.fda.gov/media/97633/download; last access date May 16, 2023.
- S. Mohapatra, R. K. Kar, P. K. Biswal and S. Bindhani, Approaches of 3D printing in current drug delivery, Sensors International. 3 (2022) Article ID 100146 (10 pages); https://doi.org/10.1016/j.sintl.2021.100146
- S. Wang, X. Chen, X. Han, X. Hong, X. Li, H. Zhang, M. Li, Z. Wang and A. Zheng, A review of 3D printing technology in pharmaceutics: Technology and applications, now and future, Pharmaceutics 15(2) (2023) Article ID 416 (29 pages); https://doi.org/10.3390/pharmaceutics15020416
- A. Bhargav, Regulatory framework in 3D printing, J. 3D Print. Med. 1(4) (2017) 213–214; https://doi.org/10.2217/3dp-2017-0014
- S. H. Lim, H. Kathuria, J. J. Y. Tan and L. Kang, 3D printed drug delivery and testing systems – a passing fad or the future?, Adv. Drug Deliv. Rev. 132 (2018) 139–168; https://doi.org/10.1016/j.addr.2018.05.006
- M. Cui, H. Pan, Y. Su, D. Fang, S. Qiao, P. Ding and W. Pan, Opportunities and challenges of three-dimensional printing technology in pharmaceutical formulation development, Acta Pharm. Sin. B. 11(8) (2021) 2488–2504; https://doi.org/10.1016/j.apsb.2021.03.015
- D. Markl, A. Zeitler, T. Rades, J. Rantanen and J. Bøtker, Toward quality assessment of 3D printed oral dosage forms, J. 3D Print. Med. 2(1) (2018) 27–33; https://doi.org/10.2217/3dp-2017-0016
- M. Deon, J. dos Santos, D. F. de Andrade and R. C. R. Beck, A critical review of traditional and advanced characterisation tools to drive formulators towards the rational development of 3D printed oral dosage forms, Int. J. Pharm. 628 (2022) Article ID 122293 (22 pages); https://doi.org/10.1016/j.ijpharm.2022.122293
- S. J. Trenfield, A. Awad, C. M. Madla, G. B. Hatton, J. Firth, A. Goyanes, S. Gaisford and A. W. Basit, Shaping the future: recent advances of 3D printing in drug delivery and healthcare, Expert Opin. Drug Deliv. 16(10) (2019) 1081–1094; https://doi.org/10.1080/17425247.2019.1660318
- J. Norman, R. D. Madurawe, C. M. V. Moore, M. A. Khan and A. Khairuzzaman, A new chapter in pharmaceutical manufacturing: 3D-printed drug products, Adv. Drug Deliv. Rev. 108 (2017) 39–50; https://doi.org/10.1016/j.addr.2016.03.001
- J. Quodbach, M. Bogdahn, J. Breitkreutz, R. Chamberlain, K. Eggenreich, A. G. Elia, N. Gottschalk, G. Gunkel-Grabole, L. Hoffmann, D. Kapote, T. Kipping, S. Klinken, F. Loose, T. Marquetant, H. Windolf, S. Geißler and T. Spitz, Quality of FDM 3D printed medicines for pediatrics: Considerations for formulation development, filament extrusion, printing process and printer design, Ther. Innov. Regul. Sci. 56(6) (2022) 910–928; https://doi.org/10.1007/s43441-021-00354-0
- G. Pitzanti, E. Mathew, G. P. Andrews, D. S. Jones and D. A. Lamprou, 3D Printing: an appealing technology for the manufacturing of solid oral dosage forms, J. Pharm. Pharmacol. 74(10) (2022) 1427–1449; https://doi.org/10.1093/jpp/rgab136
- B. Bornkamp, F. Bretz, A. Dmitrienko, G. Enas, B. Gaydos, C.-H. Hsu, F. König, M. Krams, Q. Liu, B. Neuenschwander, T. Parke, J. Pinheiro, A. Roy, R. Sax and F. Shen, Innovative approaches for designing and analyzing adaptive dose-ranging trials, J. Biopharm. Stat. 17(6) (2007) 965–995; https://doi.org/10.1080/10543400701643848
- J. A. Quinlan and M. Krams, Implementing adaptive designs: Logistical and operational considerations, Ther. Innov. Regul. Sci. 40 (2006) 437–444; https://doi.org/10.1177/216847900604000409
- R. Parhi and G. K. Jena, An updated review on application of 3D printing in fabricating pharmaceutical dosage forms, Drug Deliv. Transl. Res. 12(10) (2022) 2428–2462; https://doi.org/10.1007/s13346-021-01074-6
Language: English
Page range: 229 - 248
Accepted on: Jan 4, 2024
Published on: May 30, 2024
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2024 Klemen Kreft, Marina Fanous, Volker Möckel, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.